Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Fund Twenty8 logo

Fund Twenty8

Investments
2
Lead Investments
0

Smart Beta for Early stage investing - Fund Twenty8 The fund is the first passive EIS fund for early stage investments. It will deliver a multi-sector and large portfolio for investors. They believe Fund Twenty8 addresses two key areas currently underserved by the EIS fund market. A lack of sector diversification within a fund and a failure to benefit from a wide portfolio approach investing. Traditional early stage funds usually focus on a single sector (exposing investors to sector-specific risks) and usually only invest in 5 to 8 investments per fund. They feel there is a need in the market for a multi-sector and large portfolio fund for early stage investments. That's why they created Fund Twenty8. Fund Twenty8 offers investors access to a diversified portfolio with at least 28 investments per fund and across multiple sectors.

Founded 2015
Europe, United Kingdom
syndicateroom.com

Highlights

Focus Areas

Biotechnology
Clinical Trials
Health Care
Life Science
Medical

Investment Types

Early Stage Venture
Private Equity
Seed

Notable Investments

Lightpoint Medical logo
EnteroBiotix logo

Investment History

Team